Sitagliptin shows protective effects on pancreatic islet grafts in 1-type diabetes models
The effects of -lipoic acid on immature rats with traumatic brain injury
Berberine Improves Cognitive Impairment by Promoting Autophagic Clearance and Inhibiting Production of -amyloid in APP/tau/PS1 Mouse Model of Alzheimer's Disease
How it works Clinical evidence Comparison with other GLP-1s Market outlook References Further reading Orforglipron, the first promising oral small-molecule GLP-1, is demonstrating weight-loss and metabolic results that could reshape obesity treatment and challenge injectable standards
How it works: When you sign up, you'll take an assessment to answer questions about your eating habits, food preferences, lifestyle, and activity level
"Inherited and acquired vitamin B12 deficiencies: Which administration route to choose for supplementation?"